Xinyu Wu

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 11, 2025
An open-label phase II study: The efficiency and safety of anlotinib + eribulin in patients with HER2-negative metastatic breast cancer.

Xinyu Wu, Fei Qu, Yijia Hua

|Sep 09, 2023
Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China.

Xinyu Wu, Nan Jin, Hongfei Gao

Pageof 1

Frequent Collaborators

2 joint publications

Yongmei Yin

1 joint publications

Xiang Huang